The Valley Desk

NCT06518837 · Interventional trial

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Overall registry status Recruiting

Phase 2

Conditions HER2-Negative Breast Cancer, Hormone Receptor-Positive Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov